Reata

Showing 1 posts of 1 posts found.

Abbott pulls kidney disease trial

October 22, 2012
Research and Development, Sales and Marketing Abbott, Reata, kidney

Abbott has terminated its Phase III trial of bardoxolone methyl in patients with kidney disease and diabetes after concerns over …

The Gateway to Local Adoption Series

Latest content



Pace appoints Ken Beyer as CEO

December 10, 2025